CytoMed Therapeutics Limited

NasdaqCM:GDTC Stock Report

Market Cap: US$25.4m

CytoMed Therapeutics Limited Company Information

CytoMed Therapeutics Limited's employee growth, exchange listings and data sources

Key Information

  • Name: CytoMed Therapeutics Limited
  • Ticker: GDTC
  • Exchange: NasdaqCM
  • Founded: 2018
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$25.388m
  • Shares Outstanding: 11.54m
  • Website: https://w2.cytomed.sg

Location

  • CytoMed Therapeutics Limited
  • 1 Commonwealth Lane, No. 08-22
  • Singapore
  • 149544
  • Singapore

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GDTCNasdaqCM (Nasdaq Capital Market)YesOrdinary SharesUSUSDApr 2023
F98DB (Deutsche Boerse AG)YesOrdinary SharesDEEURApr 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 19:36
End of Day Share Price 2024/11/22 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.